Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 434.30 (2026-04-06)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Vertex Pharmaceuticals Incorporated (VRTX) had Net Income of $1.19B for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$3.19B
Net Income
$1.19B
$466.00M
$2.72B
$1.98B
$1.21B
$125.10M
$1.33B
$1.33B
$1.19B
$1.19B
$1.19B
$1.19B
$1.21B
$1.26B
255.70M
258.00M
$4.68
$4.64
Balance Sheet Financials
$11.20B
$1.52B
$14.44B
$25.64B
$3.86B
--
$3.12B
$6.98B
$18.67B
$17.15B
$18.67B
253.99M
Cash Flow Statement Financials
$3.63B
$-945.40M
$-2.26B
$4.57B
$5.09B
$515.60M
$685.90M
--
--
Fundamental Metrics & Ratios
2.90
--
--
--
--
85.39%
37.80%
37.80%
--
41.72%
37.34%
$3.19B
--
--
--
0.12
0.28
1.55
57.92
6.38%
6.94%
4.64%
6.38%
$73.49
$12.38
$14.08